Single-cell profiling of peripheral and local immune compartments reveal unique genotype-independent prognostic immune signatures across isocitrate dehydrogenase-stratified glioma

This study reveals variable expression of immune phenotypes in adult gliomas stratified by IDH status and characterizes immune compartment and genotype-dependent differences in the immunologic glioma landscape. These genotype-dependent, tumor and circulating immune ontogenies should guide future diagnostic and immunotherapeutic considerations in malignant glioma.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2025-09-18
DOI
https://doi.org/10.1093/neuonc/noaf206
Citations
1
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.63

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Single-cell profiling of peripheral and local immune compartments reveal unique genotype-independent prognostic immune signatures across isocitrate dehydrogenase-stratified glioma

Dario A.A. Vignali, Kai Tan, Jonathan Sussman, Nduka Amankulor et al.
1 citations
Neuro-Oncology
Glioma Diagnosis and Treatment
1.63
article

Single-cell profiling of peripheral and local immune compartments reveal unique genotype-independent prognostic immune signatures across isocitrate dehydrogenase-stratified glioma

Dario A.A. Vignali, Kai Tan, Jonathan Sussman, Nduka Amankulor, Wojciech K. Panek, Emily Xu, Sajeev Kohli, Tullia C. Bruno, Katharine Krueger, Jonathan Patterson, Angelo Angione, Omar Elghawy, Carly Cardello, Prajwal Rajappa, Bhargavi R. Budihal, Antonio Corral Tarbay, Ali Akbar Ghamari, Anthony R. Cillo, Alex Li, Ebrar Akca, Xiaoran Zhang, Jessica Xu, David H. Moon
article en
1 citations

Abstract

This study reveals variable expression of immune phenotypes in adult gliomas stratified by IDH status and characterizes immune compartment and genotype-dependent differences in the immunologic glioma landscape. These genotype-dependent, tumor and circulating immune ontogenies should guide future diagnostic and immunotherapeutic considerations in malignant glioma.

Neuro-OncologyVol. 28(1)
Nationwide Children's Hospital (US), Children's Hospital of Philadelphia (US), University of Pittsburgh (US), Hospital of the University of Pennsylvania (US), The Ohio State University Wexner Medical Center (US), Parker Institute for Cancer Immunotherapy (US), UPMC Hillman Cancer Center (US), University of Pittsburgh Medical Center (US), BGS Global Hospital (IN), Institute of Medical Sciences (IN), University of Pennsylvania (US)
University of Pennsylvania, University of Pittsburgh, National Institutes of Health, Center for Research Computing, University of Pittsburgh, National Cancer Institute
Openalex Percentile: Top 13%
Glioma Diagnosis and Treatment
1.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.